%0 Journal Article
%A Majidi, Azam
%A Rinaldi, Sabina
%A Biessy, Carine
%A Vozar, Beatrice
%A Truong, Therese
%A Turzanski Fortner, Renée
%A Le Cornet, Charlotte
%A Schulze, Matthias B
%A Panico, Camilla
%A Tumino, Rosario
%A Masala, Giovanna
%A Ricceri, Fulvio
%A Vener, Claudia
%A Sánchez, Maria-José
%A Zamora-Ros, Raúl
%A Crous-Bou, Marta
%A Colorado-Yohar, Sandra M
%A Guevara, Marcela
%A Israelsson, Pernilla
%A Travis, Ruth
%A Riboli, Elio
%A Fournier, Agnès
%A Dossus, Laure
%T Thyroid hormones and epithelial ovarian cancer risk and survival: results from the EPIC study.
%J Journal of the National Cancer Institute
%V nn
%@ 0027-8874
%C Oxford
%I Oxford Univ. Press
%M DKFZ-2025-01698
%P nn
%D 2025
%X Thyroid-stimulating hormone (TSH) and thyroid hormones (free triiodothyronine[fT3] and free thyroxine[fT4]) may influence cancer outcomes, but evidence for ovarian cancer is limited.We conducted a nested case-control study comparing 578 epithelial ovarian cancer (EOC) cases to matched controls within the European Prospective Investigation into Cancer and Nutrition (EPIC). To examine associations between circulating TSH, fT3, and fT4 levels and EOC risk, we estimated risk ratios (RRs) and 95
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:40811636
%R 10.1093/jnci/djaf222
%U https://inrepo02.dkfz.de/record/303508